Vaccination Trends in Patients With Heart Failure: Insights From Get With The Guidelines–Heart Failure

Ankeet S. Bhatt, Li Liang, Adam D. DeVore, Gregg C. Fonarow, Scott D. Solomon, Orly Vardeny, Clyde W. Yancy, Robert J. Mentz, Yevgeniy Khariton, Paul S. Chan, Roland Matsouaka, Barbara L. Lytle, Ileana L. Pina, Adrian F. Hernandez

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Objectives: This study sought to evaluate and contribute to the limited data on U.S. hospital practice patterns with respect to respiratory vaccination in patients hospitalized with heart failure (HF). Background: Respiratory infection is a major driver of morbidity in patients with HF, and many influenza and pneumococcal infections may be prevented by vaccination. Methods: This study evaluated patients hospitalized at centers participating in the Get With The Guidelines–HF (GWTG-HF) registry from October 2012 to March 2017. The proportion of patients receiving vaccination was described for influenza and pneumococcal vaccination, respectively. The association of hospital-level vaccination rates with individual GWTG-HF performance measures and defect-free care was evaluated using multivariable modeling. Results: This study evaluated 313,761 patients discharged from 392 hospitals during the study period. The proportion of patients receiving influenza vaccination was 68% overall and declined from 70% in 2012 to 2013 to 66% in 2016 to 2017 (p < 0.001), although this was not statistically significant after adjustment (odds ratio: 1.05 per flu season; 95% confidence interval [CI]: 0.94 to 1.18). The proportion of patients receiving pneumococcal vaccination was 66% overall and decreased over the study period from 71% in 2013 to 60% in 2016 (p < 0.001), remaining significant after adjustment (odds ratio: 0.75 per calendar year; 95% CI: 0.67 to 0.84). Hospitals with higher vaccination rates were more likely to discharge patients with higher performance on defect-free care and individual GWTG-HF performance measures (p < 0.001). In a subset of patients with linked Medicare claims, vaccinated patients had similar rates of 1-year all-cause mortality (adjusted hazard ratio: 0.96 [95% CI: 0.89 to 1.03] for influenza vaccination; adjusted hazard ratio: 0.95 [95% CI: 0.89 to 1.01] for pneumococcal vaccination) compared with those not vaccinated. Conclusions: Nearly 1 in 3 patients hospitalized with HF at participating hospitals were not vaccinated for influenza or pneumococcal pneumonia, and vaccination rates did not improve from 2012 to 2017. Hospitals that exhibited higher vaccination rates performed well with respect to other HF quality of care measures. Vaccination status was not associated with differences in clinical outcomes. Further randomized controlled data are needed to assess the relationship between vaccination and outcomes.

Original languageEnglish (US)
Pages (from-to)844-855
Number of pages12
JournalJACC: Heart Failure
Volume6
Issue number10
DOIs
StatePublished - Oct 1 2018

Fingerprint

Vaccination
Heart Failure
Human Influenza
Confidence Intervals
Odds Ratio
Pneumococcal Pneumonia
Pneumococcal Infections
Patient Discharge
Quality of Health Care
Medicare
Respiratory Tract Infections
Registries
Morbidity
Mortality

Keywords

  • heart failure
  • influenza
  • performance measures
  • pneumococcal
  • vaccination

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Bhatt, A. S., Liang, L., DeVore, A. D., Fonarow, G. C., Solomon, S. D., Vardeny, O., ... Hernandez, A. F. (2018). Vaccination Trends in Patients With Heart Failure: Insights From Get With The Guidelines–Heart Failure. JACC: Heart Failure, 6(10), 844-855. https://doi.org/10.1016/j.jchf.2018.04.012

Vaccination Trends in Patients With Heart Failure : Insights From Get With The Guidelines–Heart Failure. / Bhatt, Ankeet S.; Liang, Li; DeVore, Adam D.; Fonarow, Gregg C.; Solomon, Scott D.; Vardeny, Orly; Yancy, Clyde W.; Mentz, Robert J.; Khariton, Yevgeniy; Chan, Paul S.; Matsouaka, Roland; Lytle, Barbara L.; Pina, Ileana L.; Hernandez, Adrian F.

In: JACC: Heart Failure, Vol. 6, No. 10, 01.10.2018, p. 844-855.

Research output: Contribution to journalArticle

Bhatt, AS, Liang, L, DeVore, AD, Fonarow, GC, Solomon, SD, Vardeny, O, Yancy, CW, Mentz, RJ, Khariton, Y, Chan, PS, Matsouaka, R, Lytle, BL, Pina, IL & Hernandez, AF 2018, 'Vaccination Trends in Patients With Heart Failure: Insights From Get With The Guidelines–Heart Failure', JACC: Heart Failure, vol. 6, no. 10, pp. 844-855. https://doi.org/10.1016/j.jchf.2018.04.012
Bhatt, Ankeet S. ; Liang, Li ; DeVore, Adam D. ; Fonarow, Gregg C. ; Solomon, Scott D. ; Vardeny, Orly ; Yancy, Clyde W. ; Mentz, Robert J. ; Khariton, Yevgeniy ; Chan, Paul S. ; Matsouaka, Roland ; Lytle, Barbara L. ; Pina, Ileana L. ; Hernandez, Adrian F. / Vaccination Trends in Patients With Heart Failure : Insights From Get With The Guidelines–Heart Failure. In: JACC: Heart Failure. 2018 ; Vol. 6, No. 10. pp. 844-855.
@article{c263e02cec724a45a2c4b55614fad81c,
title = "Vaccination Trends in Patients With Heart Failure: Insights From Get With The Guidelines–Heart Failure",
abstract = "Objectives: This study sought to evaluate and contribute to the limited data on U.S. hospital practice patterns with respect to respiratory vaccination in patients hospitalized with heart failure (HF). Background: Respiratory infection is a major driver of morbidity in patients with HF, and many influenza and pneumococcal infections may be prevented by vaccination. Methods: This study evaluated patients hospitalized at centers participating in the Get With The Guidelines–HF (GWTG-HF) registry from October 2012 to March 2017. The proportion of patients receiving vaccination was described for influenza and pneumococcal vaccination, respectively. The association of hospital-level vaccination rates with individual GWTG-HF performance measures and defect-free care was evaluated using multivariable modeling. Results: This study evaluated 313,761 patients discharged from 392 hospitals during the study period. The proportion of patients receiving influenza vaccination was 68{\%} overall and declined from 70{\%} in 2012 to 2013 to 66{\%} in 2016 to 2017 (p < 0.001), although this was not statistically significant after adjustment (odds ratio: 1.05 per flu season; 95{\%} confidence interval [CI]: 0.94 to 1.18). The proportion of patients receiving pneumococcal vaccination was 66{\%} overall and decreased over the study period from 71{\%} in 2013 to 60{\%} in 2016 (p < 0.001), remaining significant after adjustment (odds ratio: 0.75 per calendar year; 95{\%} CI: 0.67 to 0.84). Hospitals with higher vaccination rates were more likely to discharge patients with higher performance on defect-free care and individual GWTG-HF performance measures (p < 0.001). In a subset of patients with linked Medicare claims, vaccinated patients had similar rates of 1-year all-cause mortality (adjusted hazard ratio: 0.96 [95{\%} CI: 0.89 to 1.03] for influenza vaccination; adjusted hazard ratio: 0.95 [95{\%} CI: 0.89 to 1.01] for pneumococcal vaccination) compared with those not vaccinated. Conclusions: Nearly 1 in 3 patients hospitalized with HF at participating hospitals were not vaccinated for influenza or pneumococcal pneumonia, and vaccination rates did not improve from 2012 to 2017. Hospitals that exhibited higher vaccination rates performed well with respect to other HF quality of care measures. Vaccination status was not associated with differences in clinical outcomes. Further randomized controlled data are needed to assess the relationship between vaccination and outcomes.",
keywords = "heart failure, influenza, performance measures, pneumococcal, vaccination",
author = "Bhatt, {Ankeet S.} and Li Liang and DeVore, {Adam D.} and Fonarow, {Gregg C.} and Solomon, {Scott D.} and Orly Vardeny and Yancy, {Clyde W.} and Mentz, {Robert J.} and Yevgeniy Khariton and Chan, {Paul S.} and Roland Matsouaka and Lytle, {Barbara L.} and Pina, {Ileana L.} and Hernandez, {Adrian F.}",
year = "2018",
month = "10",
day = "1",
doi = "10.1016/j.jchf.2018.04.012",
language = "English (US)",
volume = "6",
pages = "844--855",
journal = "JACC: Heart Failure",
issn = "2213-1779",
publisher = "Elsevier BV",
number = "10",

}

TY - JOUR

T1 - Vaccination Trends in Patients With Heart Failure

T2 - Insights From Get With The Guidelines–Heart Failure

AU - Bhatt, Ankeet S.

AU - Liang, Li

AU - DeVore, Adam D.

AU - Fonarow, Gregg C.

AU - Solomon, Scott D.

AU - Vardeny, Orly

AU - Yancy, Clyde W.

AU - Mentz, Robert J.

AU - Khariton, Yevgeniy

AU - Chan, Paul S.

AU - Matsouaka, Roland

AU - Lytle, Barbara L.

AU - Pina, Ileana L.

AU - Hernandez, Adrian F.

PY - 2018/10/1

Y1 - 2018/10/1

N2 - Objectives: This study sought to evaluate and contribute to the limited data on U.S. hospital practice patterns with respect to respiratory vaccination in patients hospitalized with heart failure (HF). Background: Respiratory infection is a major driver of morbidity in patients with HF, and many influenza and pneumococcal infections may be prevented by vaccination. Methods: This study evaluated patients hospitalized at centers participating in the Get With The Guidelines–HF (GWTG-HF) registry from October 2012 to March 2017. The proportion of patients receiving vaccination was described for influenza and pneumococcal vaccination, respectively. The association of hospital-level vaccination rates with individual GWTG-HF performance measures and defect-free care was evaluated using multivariable modeling. Results: This study evaluated 313,761 patients discharged from 392 hospitals during the study period. The proportion of patients receiving influenza vaccination was 68% overall and declined from 70% in 2012 to 2013 to 66% in 2016 to 2017 (p < 0.001), although this was not statistically significant after adjustment (odds ratio: 1.05 per flu season; 95% confidence interval [CI]: 0.94 to 1.18). The proportion of patients receiving pneumococcal vaccination was 66% overall and decreased over the study period from 71% in 2013 to 60% in 2016 (p < 0.001), remaining significant after adjustment (odds ratio: 0.75 per calendar year; 95% CI: 0.67 to 0.84). Hospitals with higher vaccination rates were more likely to discharge patients with higher performance on defect-free care and individual GWTG-HF performance measures (p < 0.001). In a subset of patients with linked Medicare claims, vaccinated patients had similar rates of 1-year all-cause mortality (adjusted hazard ratio: 0.96 [95% CI: 0.89 to 1.03] for influenza vaccination; adjusted hazard ratio: 0.95 [95% CI: 0.89 to 1.01] for pneumococcal vaccination) compared with those not vaccinated. Conclusions: Nearly 1 in 3 patients hospitalized with HF at participating hospitals were not vaccinated for influenza or pneumococcal pneumonia, and vaccination rates did not improve from 2012 to 2017. Hospitals that exhibited higher vaccination rates performed well with respect to other HF quality of care measures. Vaccination status was not associated with differences in clinical outcomes. Further randomized controlled data are needed to assess the relationship between vaccination and outcomes.

AB - Objectives: This study sought to evaluate and contribute to the limited data on U.S. hospital practice patterns with respect to respiratory vaccination in patients hospitalized with heart failure (HF). Background: Respiratory infection is a major driver of morbidity in patients with HF, and many influenza and pneumococcal infections may be prevented by vaccination. Methods: This study evaluated patients hospitalized at centers participating in the Get With The Guidelines–HF (GWTG-HF) registry from October 2012 to March 2017. The proportion of patients receiving vaccination was described for influenza and pneumococcal vaccination, respectively. The association of hospital-level vaccination rates with individual GWTG-HF performance measures and defect-free care was evaluated using multivariable modeling. Results: This study evaluated 313,761 patients discharged from 392 hospitals during the study period. The proportion of patients receiving influenza vaccination was 68% overall and declined from 70% in 2012 to 2013 to 66% in 2016 to 2017 (p < 0.001), although this was not statistically significant after adjustment (odds ratio: 1.05 per flu season; 95% confidence interval [CI]: 0.94 to 1.18). The proportion of patients receiving pneumococcal vaccination was 66% overall and decreased over the study period from 71% in 2013 to 60% in 2016 (p < 0.001), remaining significant after adjustment (odds ratio: 0.75 per calendar year; 95% CI: 0.67 to 0.84). Hospitals with higher vaccination rates were more likely to discharge patients with higher performance on defect-free care and individual GWTG-HF performance measures (p < 0.001). In a subset of patients with linked Medicare claims, vaccinated patients had similar rates of 1-year all-cause mortality (adjusted hazard ratio: 0.96 [95% CI: 0.89 to 1.03] for influenza vaccination; adjusted hazard ratio: 0.95 [95% CI: 0.89 to 1.01] for pneumococcal vaccination) compared with those not vaccinated. Conclusions: Nearly 1 in 3 patients hospitalized with HF at participating hospitals were not vaccinated for influenza or pneumococcal pneumonia, and vaccination rates did not improve from 2012 to 2017. Hospitals that exhibited higher vaccination rates performed well with respect to other HF quality of care measures. Vaccination status was not associated with differences in clinical outcomes. Further randomized controlled data are needed to assess the relationship between vaccination and outcomes.

KW - heart failure

KW - influenza

KW - performance measures

KW - pneumococcal

KW - vaccination

UR - http://www.scopus.com/inward/record.url?scp=85056466612&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056466612&partnerID=8YFLogxK

U2 - 10.1016/j.jchf.2018.04.012

DO - 10.1016/j.jchf.2018.04.012

M3 - Article

AN - SCOPUS:85056466612

VL - 6

SP - 844

EP - 855

JO - JACC: Heart Failure

JF - JACC: Heart Failure

SN - 2213-1779

IS - 10

ER -